Home » Stocks » 5:01 Acquisition

5:01 Acquisition Corp. (FVAM)

Stock Price: $10.10 USD 0.10 (1.00%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 104.64M
Revenue (ttm) n/a
Net Income (ttm) -993
Shares Out 10.36M
EPS (ttm) 0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $10.10
Previous Close $10.00
Change ($) 0.10
Change (%) 1.00%
Day's Open 10.10
Day's Range 10.00 - 10.20
Day's Volume 68,328
52-Week Range 9.98 - 11.00

More Stats

Market Cap 104.64M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 10.36M
Float n/a
EPS (basic) n/a
EPS (diluted) 0.00
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income n/a
Net Income -993
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name 5:01 Acquisition Corp.
Country United States
CEO Kush M. Parmar

Stock Information

Ticker Symbol FVAM
Stock Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Unique Identifier NASDAQ: FVAM
IPO Date October 14, 2020


5:01 Acquisition is a newly organized blank check company incorporated in August 2020 as a Delaware corporation whose primary business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to initially focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business. In particular, we intend to target early stage North American or European companies in the biotechnology sector of the healthcare industry where our management has extensive investment and operational experience. We may also pursue a transaction in which our stockholders immediately prior to the completion of our initial business combination would collectively own a minority interest in the post-business combination company.